CClinicalTrials.gg
CompletedNCT02899208Updated Jul 2, 2017

Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?

An observational study in Critical Illness, Quality of Life and Physical Activity, sponsored by Zealand University Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-07-02.

Sponsored by Zealand University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to investigate whether an actigraph, measuring in-hospital activity, used for a week after discharge from the ICU at Zealand University Hospital Køge, can predict physical function at three-month follow up.

The hospital activity will be measured with actigraphy, a measurement tool that quantifies activity level. The activity will be measured for 7 days after ICU discharge. The actigraph is to be worn as a bracelet.

The physical function will be measured with Chelsea Critical Care Physical Assessment Tool (CPAx). CPAx is assessed at ICU discharge and after three months.

Read the detailed description

Treatment at an Intensive Care Unit (ICU) is often needed for the survival of critically ill patients, but it can take a long time to recover. A number of high quality studies have shown that patients experience functional impairments for a long period after discharge, even for years.

These patients may suffer from a number of other negative influences of their critical illness and ICU stay, e.g. memory problems, episodes of depression, cognitive dysfunction and sleeping disorders. These symptoms are seen in both medical and surgical patients and has been named the Post Intensive Care Syndrome.

Physical rehabilitation is important and must start already during admission, in order to regain some of the function and independence of the patients. This has a well documented effect on both mental and physical wellbeing.

Actigraphy is a newer way of quantifying the activity level continuously. It is validated and has been used in the ICU to assess agitation and sedation and in an oncological, surgical and even an ICU population to assess sleep.

It is easy to use, non-invasive and inexpensive. It is worn like a bracelet and doesn't impair the patients mobility or ambulation.

Another issue when evaluating physical impairments is the choice of method for assessing physical function. For this study, the investigators use the Chelsea Critical Care Physical Assessment Tool (CPAx) as it has good validity and clinimetric properties and is easy to use. Also, it can be done as part of the daily training as it is developed specifically for the ICU.

The aim of this study is to investigate how the in-hospital activity level of patients after ICU discharge is associated with their physical function at three months post discharge.

02

Conditions studied

  • Critical Illness
  • Quality of Life
  • Physical Activity

Browse trials for

03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 40 is below the median of 130 across 867 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Zealand University Hospital is the lead sponsor of 234 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients admitted to the ICU at Zealand University Hospital, Køge, in the study period

Inclusion criteria

  • Patients > 18 years of age
  • Admitted to the ICU for > 24 h

Exclusion criteria

Exclusion Criteria:

  • Not able to speak and understand Danish
  • Patients suffering from dementia or psychosis
  • Discharged from the ICU to terminal care
  • Patients transferred to another hospital during ICU stay
  • Patients living outside the Region of Zealand
  • Patients suffering from total paralysis before admission
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The association between actigraph levels and CPAx at three months after discharge from ICU

    The association between actigraph levels and CPAx score (from 0 to 50 points)

    Time frame: 3 months after discharge from intensive care unit

Secondary outcomes

  1. CPAx at discharge from ICU

    CPAx score (from 0 to 50 points)

    Time frame: Within 24 hours of discharge from intensive care unit

  2. Activity measured with actigraph during one week after ICU-discharge

    Activity measured with an actigraph watch placed on the patients' wrist

    Time frame: One week after discharge from ICU

  3. Association between early activity level measured with actigraphy for 7 days and SF 36 at three months after discharge from ICU

    The association between actigraph levels and SF-36 score

    Time frame: 3 months after discharge from intensive care unit

  4. Association between early activity level measured with actigraphy for 7 days and Hospital Anxiety and Depression Scale (HADS) at three months after discharge from ICU

    The association between actigraph levels and HADS score (from 0 to 42 points)

    Time frame: 3 months after discharge from intensive care unit

  5. Association between early activity level measured with actigraphy for 7 days and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) at three months after discharge from ICU

    The association between actigraph levels and RBANS score

    Time frame: 3 months after discharge from intensive care unit

  6. Association between early activity level measured with actigraphy for 7 days and mortality within hospital stay, after ICU discharge

    The association between actigraph levels and hospital mortality

    Time frame: The period within hospital stay, after intensive care unit discharge

  7. Association between early activity level measured with actigraphy for 7 days and mortality within 90 days after ICU discharge

    The association between actigraph levels and 90-day mortality

    Time frame: 3 months after discharge from intensive care unit

  8. Association between early activity level measured with actigraphy for 7 days and consumption of opioids (strong/weak) at 90 days follow up.

    The association between actigraph levels and opioid-consumtion (morphine-equivalents)

    Time frame: 3 months after discharge from intensive care unit

07

Study locations

1 site
  • Zealand University Hospital
    Køge, 4600, Denmark
08

References and documents

Publications

  • Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011 Apr 7;364(14):1293-304. doi: 10.1056/NEJMoa1011802. PubMed 21470008 ↗
  • Grap MJ, Borchers CT, Munro CL, Elswick RK Jr, Sessler CN. Actigraphy in the critically ill: correlation with activity, agitation, and sedation. Am J Crit Care. 2005 Jan;14(1):52-60. PubMed 15608109 ↗
  • Parry SM, Granger CL, Berney S, Jones J, Beach L, El-Ansary D, Koopman R, Denehy L. Assessment of impairment and activity limitations in the critically ill: a systematic review of measurement instruments and their clinimetric properties. Intensive Care Med. 2015 May;41(5):744-62. doi: 10.1007/s00134-015-3672-x. Epub 2015 Feb 5. PubMed 25652888 ↗
  • Corner EJ, Wood H, Englebretsen C, Thomas A, Grant RL, Nikoletou D, Soni N. The Chelsea critical care physical assessment tool (CPAx): validation of an innovative new tool to measure physical morbidity in the general adult critical care population; an observational proof-of-concept pilot study. Physiotherapy. 2013 Mar;99(1):33-41. doi: 10.1016/j.physio.2012.01.003. Epub 2012 Mar 30. PubMed 23219649 ↗
  • Corner EJ, Soni N, Handy JM, Brett SJ. Construct validity of the Chelsea critical care physical assessment tool: an observational study of recovery from critical illness. Crit Care. 2014 Mar 27;18(2):R55. doi: 10.1186/cc13801. PubMed 24669784 ↗
  • Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med. 2013 Oct 3;369(14):1306-16. doi: 10.1056/NEJMoa1301372. PubMed 24088092 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02899208
Lead sponsor
Zealand University Hospital
Responsible party
Sponsor
First posted
Sep 14, 2016
Start date
Sep 2016
Primary completion
May 25, 2017
Completion
May 25, 2017
Last update
Jul 2, 2017

Study contacts

Stine Estrup, MD
principal investigator · Zealand University Hospital, Køge Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion